DEVELOPMENT OF A NEW MAMMALIAN CELL EXPRESSION SYSTEM

Information

  • Research Project
  • 3498410
  • ApplicationId
    3498410
  • Core Project Number
    R43GM043638
  • Full Project Number
    1R43GM043638-01
  • Serial Number
    43638
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/27/1989 - 35 years ago
  • Project End Date
    3/26/1990 - 34 years ago
  • Program Officer Name
  • Budget Start Date
    9/27/1989 - 35 years ago
  • Budget End Date
    3/26/1990 - 34 years ago
  • Fiscal Year
    1989
  • Support Year
    1
  • Suffix
  • Award Notice Date
    9/25/1989 - 35 years ago
Organizations

DEVELOPMENT OF A NEW MAMMALIAN CELL EXPRESSION SYSTEM

Numerous expression systems exist for production of proteins in both prokaryotic and eukaryotic cells. Each system has its own set of advantages as well as shortcomings. This need remains for a mammalian cell expression system that can achieve high level target gene expression, correctly process proteins of mammalian origin, and is economical and easy to use. Recently, we have established a mammalian expression system capable of significant production levels of target proteins. This system is based on coinfection of cultured cells with two recombinant vaccinia viruses. One recombinant vaccinia virus provides constitutive expression of bacteriophage T7 RNA polymerase, and the second contains a T7-promoter-controlled target gene. The two virus system was required for stability reasons. We plan to use the regulatory elements of the Escherichia coli lac operator/repressor system to regulate expression of T7 RNA polymerase. If expression of T7 RNA polymerase could be controlled, a single virus expression system may be feasible. If successful, this system will be exploited as a superior means for the efficient bioproduction of mammalian proteins.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R43
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    821
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    SSS
  • Study Section Name
  • Organization Name
    MEDIMMUNE, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    GAITHERSBURG
  • Organization State
    MD
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    20878
  • Organization District
    UNITED STATES